We are live on
!
Find out more
AWE
Avidian Wealth Enterprises Portfolio holdings
AUM
$3.62B
1-Year Est. Return
24.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.41%
1 Year Est. Return
+24.8%
3 Year Est. Return
+63.73%
5 Year Est. Return
+69.22%
10 Year Est. Return
+195.65%
AUM
$374M
AUM Growth
+$111M
(+42%)
Cap. Flow
+$1.81M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
73.36%
Holding
112
New
20
Increased
37
Reduced
31
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$10.7M |
| 2 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$2.89M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$2.7M |
| 4 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$1.9M |
| 5 |
iShares Core S&P US Value ETF
IUSV
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$33.2M |
| 2 |
CoStar Group
CSGP
|
+$947K |
| 3 |
Sinclair Inc
SBGI
|
+$544K |
| 4 |
Integra LifeSciences
IART
|
+$520K |
| 5 |
UGAZ
VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2
UGAZ
|
+$441K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 74.35% |
| 2 | Healthcare | 17.18% |
| 3 | Energy | 3.24% |
| 4 | Technology | 1.82% |
| 5 | Industrials | 0.9% |
Similar funds
HIMC
CC
VVP
VGM
OCM
PA
MMI
WPC
Avidian Wealth Enterprises's Q4 2017 Portfolio in Review
As of Q4 2017, Avidian Wealth Enterprises held 112 positions worth $374M, up 42% from $262M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Avidian Wealth Enterprises's Q4 2017 filing shows 20 new, 37 increased, 31 reduced and 7 closed positions. Its largest new stake was iShares Biotechnology ETF: 99,749 shares worth $10.7M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $33.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 88% a quarter earlier, followed by Healthcare and Energy.
- Avidian Wealth Enterprises's largest Q4 2017 buy was iShares Biotechnology ETF: 99,749 shares worth $10.7M.
- Avidian Wealth Enterprises added most to Schwab Short-Term US Treasury ETF in Q4 2017, an estimated $2.89M increase.
- Avidian Wealth Enterprises's biggest Q4 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $33.2M.
- Avidian Wealth Enterprises fully exited CoStar Group in Q4 2017, selling an estimated $947K.
- Avidian Wealth Enterprises's ten largest holdings make up 73% of its $374M portfolio in Q4 2017.
- Avidian Wealth Enterprises opened 20 new positions and closed 7 in Q4 2017.
- Avidian Wealth Enterprises's portfolio value rose 42% quarter-over-quarter to $374M.
Based on Avidian Wealth Enterprises's 13F filing for Q4 2017, filed 14 Feb 2018.